Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| SENESCO TECHNOLOGIES INC | 456,364 | reported | 18 Nov 2014 | tx 2+456,364 |
| Jasper Therapeutics, Inc. | 234,000 | reported | 02 Jan 2026 | tx 14+4,614,409−175,062 |
| NEORX CORP | 50,000 | reported | 06 Oct 2011 | tx 21+3,092,205−535,958 |
| PLUS THERAPEUTICS, INC. | 50,000 | reported | 26 Jan 2017 | tx 1+50,000 |
| NeurogesX Inc | 25,000 | reported | 01 Jan 2013 | tx 8+1,225,000−625,000 |
| KALOBIOS PHARMACEUTICALS INC | 3,125 | reported | 28 Oct 2015 | tx 8+122,500 |
| IMCLONE SYSTEMS INC/DE | 0 | reported | 04 Aug 2006 | tx 17+53,284−56,777 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | Jasper Therapeutics, Inc. | 234,000 | 0.00 USD | deriv |
| 22 Sept 2025 | PURCHASE | Jasper Therapeutics, Inc. | 41,000 | 2.43 USD | first after silence |
| 22 Sept 2025 | PURCHASE | Jasper Therapeutics, Inc. | 41,000 | — | deriv |
| 04 Jun 2025 | GRANT_AWARD | Jasper Therapeutics, Inc. | 234,000 | 0.00 USD | deriv |
| 13 Feb 2025 | GRANT_AWARD | Jasper Therapeutics, Inc. | 130,000 | 0.00 USD | deriv |
| 10 Jun 2024 | GRANT_AWARD | Jasper Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 10 Jun 2024 | GRANT_AWARD | Jasper Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 15 Feb 2024 | GRANT_AWARD | Jasper Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |
| 12 Oct 2023 | TAX_WITHHOLDING | Jasper Therapeutics, Inc. | 87,531 | 0.85 USD | |
| 12 Apr 2023 | TAX_WITHHOLDING | Jasper Therapeutics, Inc. | 87,531 | 1.46 USD | |
| 17 Mar 2023 | GRANT_AWARD | Jasper Therapeutics, Inc. | 500,000 | 0.00 USD | deriv |
| 02 Feb 2023 | GRANT_AWARD | Jasper Therapeutics, Inc. | 1,093,831 | 0.00 USD | deriv |
| 12 Oct 2022 | GRANT_AWARD | Jasper Therapeutics, Inc. | 506,250 | 0.00 USD | |
| 21 Mar 2022 | GRANT_AWARD | Jasper Therapeutics, Inc. | 1,704,328 | 0.00 USD | deriv |
| 26 Jan 2017 | GRANT_AWARD | PLUS THERAPEUTICS, INC. | 50,000 | 0.00 USD | deriv |
| 28 Oct 2015 | GRANT_AWARD | KALOBIOS PHARMACEUTICALS INC | 3,125 | 0.00 USD | deriv |
| 28 Sept 2015 | GRANT_AWARD | KALOBIOS PHARMACEUTICALS INC | 3,125 | 0.00 USD | deriv |
| 28 Aug 2015 | GRANT_AWARD | KALOBIOS PHARMACEUTICALS INC | 3,125 | 0.00 USD | deriv |
| 30 Jul 2015 | GRANT_AWARD | KALOBIOS PHARMACEUTICALS INC | 3,125 | 0.00 USD | deriv |
| 29 Jun 2015 | GRANT_AWARD | KALOBIOS PHARMACEUTICALS INC | 25,000 | 0.00 USD | deriv |
| 28 May 2015 | GRANT_AWARD | KALOBIOS PHARMACEUTICALS INC | 25,000 | 0.00 USD | deriv |
| 22 Apr 2015 | GRANT_AWARD | KALOBIOS PHARMACEUTICALS INC | 30,000 | 0.00 USD | deriv |
| 22 Apr 2015 | GRANT_AWARD | KALOBIOS PHARMACEUTICALS INC | 30,000 | 0.00 USD | deriv |
| 18 Nov 2014 | GRANT_AWARD | SENESCO TECHNOLOGIES INC | 56,364 | 0.00 USD | deriv |
| 01 Jan 2013 | EXERCISE | NeurogesX Inc | 25,000 | 0.00 USD |
1 purchase reported after at least 12 months of silence — most recent on 22 Sept 2025.